Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)
CUSIP: 604749101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 60,799,281
- Total 13F shares
- 53,362,791
- Share change
- +91,308
- Total reported value
- $1,824,471,702
- Put/Call ratio
- 64%
- Price per share
- $34.19
- Number of holders
- 157
- Value change
- +$17,964,526
- Number of buys
- 87
- Number of sells
- 83
Quarterly Holders Quick Answers
What is CUSIP 604749101?
CUSIP 604749101 identifies MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 604749101:
Top shareholders of MIRM - Mirum Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
11%
|
6,495,392
|
$163,164,247 | — | 31 Mar 2024 | |
| BVF INC/IL |
13F
|
Company |
7.2%
|
4,370,024
|
$109,775,003 | — | 31 Mar 2024 | |
| James E. Flynn |
3/4/5
|
* Possible Member of 10% Group, 10%+ Owner |
—
class O/S missing
|
3,244,434
|
$90,958,032 | — | 06 Jun 2022 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
5.4%
|
3,300,400
|
$82,906,048 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
2,822,472
|
$70,900,497 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.6%
|
2,767,210
|
$69,470,310 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4%
|
2,452,273
|
$61,601,098 | — | 31 Mar 2024 | |
| NEA Partners 16, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,186,243
|
$61,291,541 | — | 13 Jun 2023 | |
| New Enterprise Associates 16, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,186,243
|
$61,291,541 | — | 13 Jun 2023 | |
| CADIAN CAPITAL MANAGEMENT, LP |
13F
|
Company |
3.8%
|
2,292,567
|
$57,589,283 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
2,211,685
|
$55,557,528 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
3.1%
|
1,856,564
|
$46,636,888 | — | 31 Mar 2024 | |
| Niall O'Donnell |
3/4/5
|
Director |
—
class O/S missing
|
1,621,118
|
$45,448,205 | — | 11 Nov 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.6%
|
1,597,506
|
$40,131,000 | — | 31 Mar 2024 | |
| Novo Holdings A/S |
13F
|
Company |
2.5%
|
1,500,000
|
$37,680,000 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.3%
|
1,392,506
|
$34,979,751 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2%
|
1,187,107
|
$29,820,128 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
1.9%
|
1,142,850
|
$28,708,392 | — | 31 Mar 2024 | |
| First Turn Management, LLC |
13F
|
Company |
1.6%
|
958,654
|
$24,081,388 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.6%
|
955,914
|
$24,012,560 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.5%
|
941,374
|
$23,647,315 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
700,116
|
$17,586,914 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
697,139
|
$17,515,213 | — | 31 Mar 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
1%
|
627,272
|
$15,757,073 | — | 31 Mar 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
1%
|
625,000
|
$15,700,000 | — | 31 Mar 2024 | |
| AXA S.A. |
13F
|
Company |
0.98%
|
593,786
|
$14,915,904 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.89%
|
539,666
|
$13,556,410 | — | 31 Mar 2024 | |
| Prosight Management, LP |
13F
|
Company |
0.76%
|
465,000
|
$11,680,800 | — | 31 Mar 2024 | |
| BOONE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.74%
|
451,898
|
$11,351,678 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.61%
|
371,051
|
$9,320,801 | — | 31 Mar 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
0.6%
|
362,193
|
$9,098,288 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.58%
|
354,588
|
$8,907,250 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.51%
|
312,613
|
$7,852,838 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.51%
|
311,185
|
$7,816,967 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.46%
|
281,079
|
$7,060,704 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.45%
|
274,866
|
$6,904,635 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.45%
|
271,654
|
$6,823,948 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.44%
|
266,262
|
$6,688,501 | — | 31 Mar 2024 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.43%
|
263,584
|
$6,621,229 | — | 31 Mar 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.43%
|
260,000
|
$6,531,200 | — | 31 Mar 2024 | |
| Penn Capital Management Company, LLC |
13F
|
Company |
0.4%
|
245,696
|
$6,180,002 | — | 31 Mar 2024 | |
| ARDSLEY ADVISORY PARTNERS LP |
13F
|
Company |
0.4%
|
245,000
|
$6,154,400 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.4%
|
244,151
|
$6,133,073 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.4%
|
241,498
|
$6,066,430 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.38%
|
233,267
|
$5,859,667 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.37%
|
222,614
|
$5,592,064 | — | 31 Mar 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.35%
|
214,887
|
$5,397,961 | — | 31 Mar 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.34%
|
208,000
|
$5,224,960 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.32%
|
197,000
|
$4,948,640 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.32%
|
196,679
|
$4,940,576 | — | 31 Mar 2024 |
Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q2 2024
As of 30 Jun 2024,
Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,362,791 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., JANUS HENDERSON GROUP PLC, BVF INC/IL, EVENTIDE ASSET MANAGEMENT, LLC, BlackRock Inc., VANGUARD GROUP INC, Rock Springs Capital Management LP, CITADEL ADVISORS LLC, Novo Holdings A/S, and STATE STREET CORP.
This page lists
158
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
167
Q2 2024 holders
157
Holder diff
-10
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.